Research
Cellular
GLP-1 medicines may contribute to decreased cancer incidence.
Consider the potential cancer risk reduction when prescribing GLP-1 medicines.
StrongQualifiesmedium confidence
thus improving outcomes for people with type 2 diabetes and obesity and potentially contributing to decreased cancer incidence.
Why this rating
The claim is based on data from trials and registries.
Source
Glucagon-like peptide-1 medicines and cancer
Julian M. Yabut et al. · Nature Cancer · 2026
DOI 10.1038/s43018-025-01110-1
otherCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →